Cole from Bulgaria

Registered at the short selling broker Skilling, 5 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

CVS Health Corp. (CVS) shares information

CVS Health Corp.


24h Change

-0.45 %

CVS

Live rate: Market closed

Stock data per Thursday 13 Aug, 2020

CVS
New York Stock Exchange
64.99
64.57
64.70
-0.29 (-0.45%)
US Market is closed

Live Stock price in graph for CVS Health Corp. (CVS)

  • Latest Volume

    6,557,999 (-4.5 %)

  • Volume prev. day

    6,867,332

  • Avg. daily volume

    6,842,764

  • Market cap

    84,672,890,000

  • P/E ratio

    10.23

  • Today high

    64.975

  • Today low

    64.05

  • 52 week high

    77.03

  • 52 week low

    52.04

  • YTD Change

    n/a

Quick links

Broker recommendations for CVS Health Corp.

The CVS Health Corp. stock is rated at 1.25 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Wednesday 12 August, 2020 by a total of 26 brokers. This means that the consensus of the 26 different brokers is leaning toward to buy/moderate buy.

Sell
0 (0%)
Underweight
0 (0%)
Hold
6 (23.08%)
Overweight
1 (3.85%)
Buy
19 (73.08%)

Price target by analysts

The 23 latest analyst estimates, per Wednesday 12 August, 2020, show the following high, low and average price targets.
Target Average: 80.65 USD
Target High: 104 USD
Target Low: 65 USD

 

Latest news about CVS Health Corp.

Below you can find the most recent news posts about CVS Health Corp., primarily from US and UK based news sources.

10 healthcare startups that could be M&A targets after Teladoc’s record-breaking $18.5 billion deal for Livongo

Thursday, 13 August 2020, 17:53:53
On August 5, telehealth giant Teladoc struck an $18.5 billion deal to buy Livongo , a chronic-care company. The record deal is sending shockwaves through an industry that analysts say is ripe for more mergers and acquisitions. Business Insider asked 10 venture capitalists and analysts about the impending consolidation in digital health. They listed 10 startups in mental health, drug research, telehealth, and more that are likely to be acquired or make deals of their own soon. For more stories like this, sign up here for our healthcare newsletter, Dispensed . On August 5, telehealth giant Teladoc struck an $18.5 billion deal to buy Livongo , a chronic-care company. It’s the biggest deal in digital health history, and it’s sending shockwaves through an industry that’s ripe for more mergers and acquisitions, according to Rock Health, a digital health venture fund and advisory firm. “This announcement is merely the starter’s pistol for an inevitable virtual care platforms race,” wrote Sari Kaganoff, a general manager at Rock Health, in a report on August 6 .
— Business Insider


CVS Becomes First Retailer To Introduce PayPal QR Codes At Checkout

Wednesday, 12 August 2020, 20:00:00
DUBLIN, Aug. 12, 2020 /PRNewswire/ — ResearchAndMarkets.com published a new article on the contactless payment industry CVS Becomes First Retailer To Introduce PayPal QR Codes At Checkout CVS will become the first retailer to introduce PayPal QR code technology at checkout in its 8,200…
— PR Newswire


CVS Health Corporation Announces Cash Tender Offers for Certain Outstanding Notes

Wednesday, 12 August 2020, 14:25:00
WOONSOCKET, R.I., Aug. 12, 2020 /PRNewswire/ — CVS Health Corporation (“CVS Health”, NYSE: CVS) announced today that it has commenced cash tender offers (each, a “Tender Offer” and collectively, the “Tender Offers”) for (i) up to $3,000,000,000 aggregate principal amount (the “2023 Notes…
— PR Newswire


Analyst Breaks Down CVS Health’s ‘Complicated’ Quarter

Tuesday, 11 August 2020, 19:31:29
CVS Health Corp’s (NYSE: CVS ) second-quarter earnings report can be defined as “more good than bad” yet the stock still trades at a discounted valuation, according to BofA Securities. The CVS Analyst: Michael Cherny maintains a Buy rating on CVS with an $80 price target. The CVS Thesis: The second-quarter report, which was released on Aug 5., was mixed as the Health Care Benefits unit reported an EBIT that was 48% higher than expected, the Pharmacy Services unit outperformed by 7%, but the Retail/Long Term Care underperformed by around 16%. However, Cherny said the Pharmacy Services business underperformed compared to other analysts’ expectations, making it the “most complicated quarter in the history of the market to model.” Looking forward, it’s difficult to determine an appropriate baseline for CVS and … Full story available on Benzinga.com
— Benzinga


CVS Health : Salesforce, CVS to Collaborate on Covid-19 Workplace Programs | MarketScreener

Monday, 10 August 2020, 14:28:02
By Matt Grossman Salesforce.com Inc. and CVS Health Corp. said Monday they will collaborate on services to help workplaces and campuses return to in-person operations following… | August 10, 2020
— MarketScreener